Clinical Study | Office of Clinical Research

A Multicenter Clinical Study Of The Sonablate? 450 (Sonablate) For The Treatment Of Locally Recurrent Prostate Cancer With Hifu

Posted Date: May 15, 2019

Investigator: James Donovan
Type of Study: Drug

The purpose of this research study is to evaluate the safety and effectiveness of the Sonablate? 450 in men with locally recurrent prostate cancer. The Sonablate? 450 is considered experimental (not approved by the Food and Drug Administration) in the United States.

Criteria:

To Qualify You Must Have Been Diagnosed With Recurrent Prostate Cancer Following External Beam Radia

Keywords:

Fsi-003 , Recurrent, Star, Cancer, Prostate

For More Information:

Uc Cancer Center
513-584-7698
kastla@ucmail.uc.edu

Name*
First Last
Gender*
- Male
- Female
Age*
Phone*
Email*
How did you hear about us?*
Future Communication*
- By submitting this form, I am agreeing to receive future communication about participating in an upcoming research study.
CAPTCHA
This contact page is monitored Monday – Friday during business hours, 8 am to 5 pm EST. Do not rely on communication through this website for medical treatment or care. This website is not designed for such purposes.
For questions regarding clinical studies at UC Health, contact us at ResearchStudies@UCHealth.com or (513) 245-3417.
List